EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis

Carole Y Perrot, Theodoros Karampitsakos, Jose D Herazo-Maya iD

American Journal of Physiology-Cell Physiology · 01.10.2023 · 325 (4) · C1046-C1057

DOI: 10.1152/ajpcell.00302.2023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.10.2023. Verfasst von Carole Y Perrot und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ubben Center for Pulmonary Fibrosis Research, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Morsani Colle…. Hauptthemen laut MEDLINE: Monocytes, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ubben Family Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary fibrosis results from a plethora of abnormal pathogenetic events. In idiopathic pulmonary fibrosis (IPF), inhalational, environmental, or occupational exposures in genetically and epigenetically predisposed individuals trigger recurrent cycles of alveolar epithelial cell injury, activation of coagulation pathways, chemoattraction, and differentiation of monocytes into monocyte-derived alveolar macrophages (Mo-AMs). When these events happen intermittently and repeatedly throughout the individual’s life cycle, the wound repair process becomes aberrant leading to bronchiolization of distal air spaces, fibroblast accumulation, extracellular matrix deposition, and loss of the alveolar-capillary architecture. The role of immune dysregulation in IPF pathogenesis and progression has been underscored in the past mainly after the disappointing results of immunosuppressant use in IPF patients; however, recent reports highlighting the prognostic and mechanistic roles of monocytes and Mo-AMs revived the interest in immune dysregulation in IPF. In this review, we will discuss the role of these cells in the onset and progression of IPF, as well as potential targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MonocytesIdiopathic Pulmonary FibrosisHumansMacrophagesExtracellular MatrixCell DifferentiationLung

Stichwörter der Autor:innen

immunitymacrophagesmonocytespathogenesispulmonary fibrosis

Autor:innen und Institutionen

  • Ubben Center for Pulmonary Fibrosis Research, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, United St…

ORCID-Profile: Jose D Herazo-Maya

Förderung

  • Ubben Family Fund

Zitieren

APA

Perrot, C. Y., Karampitsakos, T., & Herazo-Maya, J. D. (2023). Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis. American Journal of Physiology-Cell Physiology, 325(4), C1046-C1057. https://doi.org/10.1152/ajpcell.00302.2023

Vancouver

Perrot CY, Karampitsakos T, Herazo-Maya JD. Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis. American Journal of Physiology-Cell Physiology. 2023;325(4):C1046-C1057. doi:10.1152/ajpcell.00302.2023

BibTeX
@article{Perrot2023,
  author = {Perrot, Carole Y and Karampitsakos, Theodoros and Herazo-Maya, Jose D},
  title = {Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2023},
  volume = {325},
  number = {4},
  pages = {C1046--C1057},
  doi = {10.1152/ajpcell.00302.2023}
}
Kostenlos starten →